Babesia rodhaini: The protective effect of pyruvate kinase deficiency in mice

Experimental Parasitology

Volumn 120, Issue 3, 2008, Pages 290-294

  Oka, Hideki ^a   Tabara, Akiko ^a   Fujisawa, Kohei ^a   Jinnai, Michio ^a   Nakajima, Rui ^a   Arai, Satoru ^b   Ishihara, Chiaki ^a   Tsuji, Masayoshi ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Babesia microti; Babesia rodhaini; Babesiosis; Host resistance gene; Pyruvate kinase deficiency

Indexed keywords

PYRUVATE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABESIA; BABESIA RODHAINI; BABESIOSIS; COISOGENIC STRAIN; CONTROLLED STUDY; ENZYME DEFICIENCY; ERYTHROCYTE; FEMALE; INFECTION RESISTANCE; MICROBIAL GROWTH; MOUSE; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; SURVIVAL RATE;

ANIMALS; BABESIA; BABESIOSIS; FEMALE; MICE; MICE, INBRED CBA; PARASITEMIA; PYRUVATE KINASE;

BABESIA MICROTI; BABESIA RODHAINI; MUS; RODENTIA;

EID: 53049093558     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2008.08.008     Document Type: Article

References (29)

1. Borggraefe I., Yuan J., Telford III S.R., Menon S., Hunter R., Shah S., Spielman A., Gelfand J.A., Wortis H.H., and Vannier E. Babesia microti primarily invades mature erythrocytes in mice. Infection and Immunity 74 (2006) 3204-3212
2. Clarebout G., Gamain B., Slomianny C., Camus D., and Dive D. The course of Plasmodium berghei, P. chabaudi and P. yoelii infections in beta-thalassemic mice. Parasitology 112 Pt 3 (1996) 269-276
3. Cox F.E., and Young A.S. Acquired immunity to Babesia microti and Babesia rodhaini in mice. Parasitology 59 (1969) 257-268
4. Dubey M.L., Hegde R., Ganguly N.K., and Mahajan R.C. Decreased level of 2,3-diphosphoglycerate and alteration of structural integrity in erythrocytes infected with Plasmodium falciparum in vitro. Molecular and Cellular Biochemistry 246 (2003) 137-141
5. Goethert H.K., and Telford III S.R. What is Babesia microti?. Parasitology 127 (2003) 301-309
6. Hood A.T., Fabry M.E., Costantini F., Nagel R.L., and Shear H.L. Protection from lethal malaria in transgenic mice expressing sickle hemoglobin. Blood 87 (1996) 1600-1603
7. Igarashi I., Asaba U., Xuan X., Omata Y., Saito A., Nagasawa H., Fujisaki K., Suzuki N., Iwakura Y., and Mikami T. Immunization with recombinant surface antigens p26 with Freund's adjuvants against Babesia rodhaini infection. The Journal of Veterinary Medical Science 62 (2000) 717-723
8. Igarashi I., Suzuki R., Waki S., Tagawa Y., Seng S., Tum S., Omata Y., Saito A., Nagasawa H., Iwakura Y., Suzuki N., Mikami T., and Toyoda Y. Roles of CD4(+) T cells and gamma interferon in protective immunity against Babesia microti infection in mice. Infection and Immunity 67 (1999) 4143-4148
9. Kanno H., Morimoto M., Fujii H., Tsujimura T., Asai H., Noguchi T., Kitamura Y., and Miwa S. Primary structure of murine red blood cell-type pyruvate kinase (PK) and molecular characterization of PK deficiency identified in the CBA strain. Blood 86 (1995) 3205-3210
10. Kjemtrup A.M., and Conrad P.A. Human babesiosis: an emerging tick-borne disease. International Journal for Parasitology 30 (2000) 1323-1337
11. Koyanagi Y., Tanaka Y., Kira J., Ito M., Hioki K., Misawa N., Kawano Y., Yamasaki K., Tanaka R., Suzuki Y., Ueyama Y., Terada E., Tanaka T., Miyasaka M., Kobayashi T., Kumazawa Y., and Yamamoto N. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain. Journal of Virology 71 (1997) 2417-2424
12. Marley S.E., Eberhard M.L., Steurer F.J., Ellis W.L., McGreevy P.B., and Ruebush II T.K. Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model. Antimicrobial Agents and Chemotherapy 41 (1997) 91-94
13. Min-Oo G., Fortin A., Tam M.F., Nantel A., Stevenson M.M., and Gros P. Pyruvate kinase deficiency in mice protects against malaria. Nature Genetics 35 (2003) 357-362
14. Min-Oo G., and Gros P. Erythrocyte variants and the nature of their malaria protective effect. Cellular Microbiology 7 (2005) 753-763
15. Min-Oo G., Tam M., Stevenson M.M., and Gros P. Pyruvate kinase deficiency: correlation between enzyme activity, extent of hemolytic anemia and protection against malaria in independent mouse mutants. Blood Cells, Molecules & Diseases 39 (2007) 63-69
16. Roth Jr. E.F., Shear H.L., Costantini F., Tanowitz H.B., and Nagel R.L. Malaria in beta-thalassemic mice and the effects of the transgenic human beta-globin gene and splenectomy. The Journal of Laboratory and Clinical Medicine 111 (1988) 35-41
17. Ruebush M.J., and Hanson W.L. Susceptibility of five strains of mice to Babesia microti of human origin. The Journal of Parasitology 65 (1979) 430-433
18. Shear H.L. Transgenic and mutant animal models to study mechanisms of protection of red cell genetic defects against malaria. Experientia 49 (1993) 37-42
19. Shear H.L., Roth Jr. E.F., Fabry M.E., Costantini F.D., Pachnis A., Hood A., and Nagel R.L. Transgenic mice expressing human sickle hemoglobin are partially resistant to rodent malaria. Blood 81 (1993) 222-226
20. Shear H.L., Roth Jr. E.F., Ng C., and Nagel R.L. Resistance to malaria in ankyrin and spectrin deficient mice. British Journal of Haematology 78 (1991) 555-560
21. Shimada T., Shikano S., Hashiguchi R., Matsuki N., and Ono K. Effects of depletion of T cell subpopulations on the course of infection and anti-parasite delayed type hypersensitivity response in mice infected with Babesia microti and Babesia rodhaini. The Journal of Veterinary Medical Science 58 (1996) 343-347
22. Takabatake N., Okamura M., Yokoyama N., Ikehara Y., Akimitsu N., Arimitsu N., Hamamoto H., Sekimizu K., Suzuki H., and Igarashi I. Glycophorin A-knockout mice, which lost sialoglycoproteins from the red blood cell membrane, are resistant to lethal infection of Babesia rodhaini. Veterinary Parasitology 148 (2007) 93-101
23. Tsuji M., Wei Q., Zamoto A., Morita C., Arai S., Shiota T., Fujimagari M., Itagaki A., Fujita H., and Ishihara C. Human babesiosis in Japan: epizootiologic survey of rodent reservoir and isolation of new type of Babesia microti-like parasite. Journal of Clinical Microbiology 39 (2001) 4316-4322
24. slc mice with a point mutation of the gene encoding red blood cell type pyruvate kinase. Blood 91 (1998) 2169-2174
25. van den B.L., Vincke I.H., Chardome M., and Van Den Bulcke M. Babesia rodhaini n. sp. of a rodent of the Belgian Congo transmissible to white mice. Annales de la Societe Belge de Medecine Tropicale 30 (1950) 83-86
26. Vannier E., Borggraefe I., Telford III S.R., Menon S., Brauns T., Spielman A., Gelfand J.A., and Wortis H.H. Age-associated decline in resistance to Babesia microti is genetically determined. The Journal of Infectious Diseases 189 (2004) 1721-1728
27. Wijaya A., Wulansari R., Ano H., and Makimura S. Effect of clindamycin therapy on phagocytic and oxidative activity profiles of spleen mononuclear cells in Babesia rodhaini-infected mice. The Journal of Veterinary Medical Science 63 (2001) 563-566
28. Wittner M., Lederman J., Tanowitz H.B., Rosenbaum G.S., and Weiss L.M. Atovaquone in the treatment of Babesia microti infections in hamsters. The American Journal of Tropical Medicine and Hygiene 55 (1996) 219-222
29. Zerez C.R., and Tanaka K.R. Impaired nicotinamide adenine dinucleotide synthesis in pyruvate kinase-deficient human erythrocytes: a mechanism for decreased total NAD content and a possible secondary cause of hemolysis. Blood 69 (1987) 999-1005